ArticleJournal of clinical and translational science2023

ACTIV-6: Operationalizing a decentralized, outpatient randomized platform trial to evaluate efficacy of repurposed medicines for COVID-19.

Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study GroupPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.